[{"Month":"June 2025","NewsReleases":[{"Title":"AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER","Date":"06.30.2025","Url":"/newsroom/press-releases/2025/06/amgen-announces-positive-topline-phase-3-results-for-bemarituzumab-in-fibroblast-growth-factor-receptor-2b-fgfr2b-positive-firstline-gastric-cancer"},{"Title":"RESULTS FROM AMGEN\u0027S PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS","Date":"06.23.2025","Url":"/newsroom/press-releases/2025/06/results-from-amgens-phase-2-obesity-study-of-monthly-maritide-presented-at-the-american-diabetes-association-85th-scientific-sessions"},{"Title":"AMGEN\u0027S PHASE 2 MARITIDE DATA TO BE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS","Date":"06.18.2025","Url":"/newsroom/press-releases/2025/06/amgens-phase-2-maritide-data-to-be-presented-at-the-american-diabetes-association-85th-scientific-sessions"},{"Title":"AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY","Date":"06.13.2025","Url":"/newsroom/press-releases/2025/06/amgen-and-football-legend-barry-sanders-highlight-dangers-of-bad-cholesterol-in-new-documentary"},{"Title":"AMGEN TO PRESENT AT GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE","Date":"06.05.2025","Url":"/newsroom/press-releases/2025/06/amgen-to-present-at-goldman-sachs-46th-annual-global-healthcare-conference"}]}]